NDC 59572-962 - ISTODAX

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
59572-962
Package NDCs from labels
59572-962-10
Manufacturer
Celgene Corporation
Effective date
2023-01-31
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ISTODAX - Celgene CorporationCelgene Corporation2023-01-31HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59572-962-10ISTODAX2.2 mL in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,2.2 mL10 mg in 2mL21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59572-962ISTODAX (ROMIDEPSIN) KIT [CELGENE CORPORATION]21Unmatched20230603_03b39d40-90fe-11df-9de6-0002a5d5c51b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
romidepsinACTIVE INGREDIENTCX3T89XQBKISTODAX (ROMIDEPSIN) KIT [CELGENE CORPORATION]13
romidepsinACTIVE MOIETYCX3T89XQBKISTODAX (ROMIDEPSIN) KIT [CELGENE CORPORATION]13
povidoneINACTIVE INGREDIENTFZ989GH94EISTODAX (ROMIDEPSIN) KIT [CELGENE CORPORATION]13